© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
October 22, 2020
Drugs often trigger outbreaks of hives, but investigators observed no clear evidence as to the overall incidence of drug allergies in CSU.
October 21, 2020
Patients who are prescribed metformin may face a risk of urticaria, though the latter can be treated with antihistamines.
October 19, 2020
FDA application is based on the positive data from 3 recent phase 3 clinical trials.
October 15, 2020
Only 29.5% of sampled CBD users claimed any wellness benefit.
Many patients do not see meaningful improvement with the current standard treatment. New data suggest this monoclonal antibody might be a better choice.
October 14, 2020
A higher proportion of risankizumab users achieved improved measures for symptoms, quality of life, and mental health versus comparators.
October 13, 2020
Though atopic dermatitis is a relatively common condition, most of the existing scientific literature has ignored the majority of patients who have mild or limited disease.
October 09, 2020
About 69% of patients with CIU were either obese or overweight, and experienced a longer duration of disease than those who had lower weight values.
October 08, 2020
New research suggests the Janus kinase 1 and 2 inhibitor relieves symptoms of atopic dermatitis at a daily dose of 4 mg.
Newly published data show routine testing is unlikely to change the management of patients with CSU.